EQS-News: invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding
EQS-News: invIOs GmbH / Key word(s): Study invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding 05.09.2023 / 09:00 CET/CEST The issuer is solely responsible for the content of this announcement. invIOs starts further c...